Uterine sarcoma.

Abstract

Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. Chemoprevention studies might target those at risk for recurrence or a second neoplasm.

• Authors: C F Levenback, G Tortolero-Luna, D K Pandey, A Malpica, V V Baker, L Whittaker, E Johnson, M Follen Mitchell
• Journal: Obstetrics and gynecology clinics of North America (Obstet Gynecol Clin North Am) Vol. 23 Issue 2 Pg. 457-73 (Jun 1996) ISSN: 0889-8545 [Print] United States
• PMID: 8784887 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review)

Chemical References

• Biomarkers, Tumor

Topics

• Biomarkers, Tumor
• Female
• Humans
• Mass Screening
• Risk Factors
• Sarcoma (epidemiology, genetics, pathology, therapy)
• Uterine Neoplasms (epidemiology, genetics, pathology, therapy)